VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1463124
Sex: F
Age:
State: SC

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe headache; Joint pain; Muscle pain; Fever of 103; Severe chills; Weakness; Still dizzy; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 25Mar2021 at 16:00 (at the age of 61-years-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not had allergy to any medications, food, or other products. Concomitant medications included melatonin (MANUFACTURER UNKNOWN) and diazepam (VALIUM); both taken for unknown indication on an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 26Mar2021 at 06:00, the patient experienced severe headache, joint and muscle pain, weakness, fever of about 103 (unknown units) and severe chills for 24 hours. The patient still felt dizzy and weak 2 days later. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken for the reported events and included treatment with TYLENOL and ibuprofen (MANUFACTURER UNKNOWN). The clinical outcomes of the events severe headache, joint and muscle pain, fever of about 103 and severe chills were resolving, while that of the event dizzy and weakness were unknown at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: MELATONIN; VALIUM

Current Illness:

ID: 1463125
Sex: F
Age:
State: MA

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: extreme lethargy on day 4; feel flu like; achey; low grade fever; overall feeling awful; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the left arm on 23Mar2021 at 12:00 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included Asthma, Meniere's Disease, Complex regional pain syndrome, POTS (Postural orthostatic tachycardia syndrome), penicillin allergy and Quinolones allergy. The patient reported that all her concomitant medications would not fit in space provided. The patient's past drug included LOVENOX and DEMEROL for unknown indications on unknown dates and experienced allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 09:00, on day 4, the patient experienced extreme lethargy, feel flu like, achey, low grade fever, major effort to get out of bed and overall feeling awful. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lethargy, flu like symptoms, ache, low grade fever and feels awful were not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1463126
Sex: F
Age:
State: PA

Vax Date: 03/18/2021
Onset Date: 03/25/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm soreness; hard at the injection site.; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Mar2021 at 15:30 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient included hashimoto's thyroiditis. The patient was allergic to sulfa and erythromycin. Concomitant medications included thyroid (ARMOUR THYROID), fluoxetine (MANUFACTURER UNKNOWN), both taken for an unknown indication and received within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 01:00, the patient had arm soreness that started one week after the injection. No rash, but also experienced hard at the injection site. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of arm soreness and hard at the injection site was resolving at the time of this report. No follow-up attempts are needed. Information about lot/ batch number cannot be obtained.

Other Meds: FLUOXETINE; ARMOUR THYROID

Current Illness:

ID: 1463127
Sex: F
Age:
State: NJ

Vax Date: 02/18/2021
Onset Date: 02/21/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Bilateral knee pain/ pain while not moving; Difficulty walking, going up and downstairs; Inability to totally straighten or bend the knee; This is a spontaneous report from a contactable other health care professional, the patient. A 38-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9266), via an unspecified route of administration in the left arm on 18Feb2021 at 16:00 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and prenatal vitamins (MANUFACTURER UNKNOWN); both from unknown dates for unspecified indications. The patient previously received naproxen (MANUFACTURER UNKNOWN) on unknown date for unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 21Feb2021, the patient experienced bilateral knee pain; lasting for five weeks, difficulty walking, going up and downstairs, pain while not moving, and inability to totally straighten or bend the knee. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with celecoxib. The clinical outcome of the events knee pain, difficulty in walking and movement reduced was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1463128
Sex: F
Age:
State: WV

Vax Date: 03/19/2021
Onset Date: 03/20/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: heavy feeling in arms and legs.; Fatigue; headache,; general malaise; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 19Mar2021 at 14:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 20Mar2021 at 17:00, the patient experienced fatigue, headache, heavy feeling in arms and legs and general malaise. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events fatigue, headache, heavy feeling in arms and legs and general malaise. The clinical outcomes of the events fatigue, headache, heavy feeling in arms and legs and general malaise were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1463129
Sex: F
Age:
State: SC

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: extremely sore left arm; fatigue; lightheaded; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733), via an unspecified route of administration in the left arm on 26Mar2021 at 04:30 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. The patient did not take any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 18:00, the patient experienced extremely sore left arm, fatigue and lightheaded. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and and included treatment with Advil. The clinical outcome of the events pain in left arm, fatigue and dizziness was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1463130
Sex: M
Age:
State: KS

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Hives; Red spot all over; Low grade fever; Site was hurting; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown); via unspecified route of administration in the left arm on 26Mar2021 (at the age 56-year-old) at 09:30 as a single dose for COVID-19 immunisation. Medical history included tachycardia, diabetes type 2, asthma, allergy to mold and bee stings. The patient was allergic to pseudoephedrine and Aavelox. Concomitant medication included atenolol (MANUFACTURER UNKNOWN) and budesonide and formoterol fumarate (SYMBICORT) for unknown indication. The patient did not receive any other vaccine within four weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 12:30, the patient experienced headaches, hives, red spots all over, low grade fever and it was also reported that site was hurting. The treatment medication involved the usage of Benadryl. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care visit. The clinical outcome of events headache, hives, red spots all over, low grade fever and site was hurting was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: ATENOLOL; SYMBICORT

Current Illness:

ID: 1463131
Sex: F
Age:
State: NV

Vax Date: 03/25/2021
Onset Date: 03/25/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle pain throughout body; headache; mild nausea; tiredness; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 25Mar2021 at 12:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included post herpetic neuralgia and hypothyroidism. The patient had allergies to sulfa drugs. Concomitant medications included gabapentin (MANUFACTURER UNKNOWN) and levothyroxine (MANUFACTURER UNKNOWN) for unknown indication from unknown date. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25Mar2021 at 19:15, the patient experienced headache, mild nausea, muscle pain throughout body and tiredness. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the adverse events. The clinical outcomes of the events headache, mild nausea, muscle pain throughout body and tiredness were recovered on an unknown date in Mar2021. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds: GABAPENTIN; LEVOTHYROXINE

Current Illness:

ID: 1463132
Sex: F
Age:
State: FL

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: soreness in arm; chills; fever 101.8; extreme fatigue; body aches; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the right arm on 25Mar2021 at 10:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Concomitant medications included ascorbic acid (VITAMIN C) started on an unknown date for an unspecified indication. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 00:00, the patient experienced soreness in arm, chills, fever (101.8), extreme fatigue and body aches. The patient had tested for body temperature on 26Mar2021 and resulted 101.8 (unspecified units). Therapeutic measure was taken as result of events and included treatment with Tylenol. The events had not resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events soreness in arm, chills, fever (101.8), extreme fatigue and body aches were resolved on 27Mar2021. No follow up attempts are needed. No further information is expected.

Other Meds: Vitamin C

Current Illness:

ID: 1463133
Sex: F
Age:
State: CA

Vax Date: 03/07/2021
Onset Date: 03/08/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: red rash in the roof of the mouth; Fever; chills; body ache; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route of administration in the left arm on 07Mar2021 at 14:15 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included G6PD deficiency, COVID-19 and sulfonamide allergy. Concomitant medication included levothyroxine sodium (SYNTHYROID) from unknown date for unspecified indication. The patient previously received acetylsalicylic acid (ASPIRIN) on unknown date for unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 08Mar2021, next day, the patient experienced fever, chill, body ache and after 6 days on 13Mar2021, the patient experienced red rash in the roof of the mouth that lasted 5 days and was very uncomfortable, never had it before. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcomes of the events fever, chills, body ache was recovered on an unspecified date in Mar2021 and of the event red rash in the roof of the mouth was recovered on 18Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1463134
Sex: F
Age:
State: VT

Vax Date: 03/23/2021
Onset Date: 03/23/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: LT deltoid redness, radiating to LT side of chest; full face flushing; This is a spontaneous report from a contactable other healthcare professional, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8730), via an unspecified route of administration in the left arm on 23Mar2021 at 13:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer for which she was on aromatase inhibitor. Concomitant medication included exemestane (MANUFACTURER UNKNOWN), Vitamin d (MANUFACTURER UNKNOWN) and calcium (MANUFACTURER UNKNOWN); all for unknown indication. The patient had a history of allergy to iodine contrast dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 23Mar2021 at 14:15, the patient had experienced left deltoid redness which was radiating to left side of chest and full-face flushing. The patient also reported that it lasted approximately for 90 minutes. Adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events left deltoid redness, radiating to left side of chest and full face flushing was resolved on 23Mar2021 at 15:45. No follow-up attempts are needed. No further information is expected.

Other Meds: EXEMESTANE; CALCIUM; VITAMIN D NOS

Current Illness:

ID: 1463135
Sex: M
Age:
State: AL

Vax Date: 03/19/2021
Onset Date: 03/25/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration in the left arm on 19Mar2021( at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not take any concomitant medications. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), via an unspecified route of administration in the left arm on 26Feb2021 at 07:45 ( at the age of 61-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19 and since the vaccination the patient had been tested for COVID -19. On 25Mar2021 at 13:00 the patient experienced fever which began 6 days after second injection and now it was over 72 hours with fever. The patient underwent lab tests which included PCR test on 26Mar2021 and tested negative. The clinical outcome of the fever was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained

Other Meds:

Current Illness:

ID: 1463136
Sex: F
Age:
State: AZ

Vax Date: 03/18/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Overall malaise; Body aches; sweats; Fever; Chills; Nausea; Diarrhea; Rash on left arm; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the left arm on 18Mar2021 at 21:00 (at the age of 29-years-old) as a single dose for COVID-19 Immunisation. Medical history was reported as thyroid. Concomitant medications included levothyroxine sodium (SYNTHROID) 135mcg received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 26Mar2021 the patient experienced fever, chills, sweats, body aches, nausea, diarrhoea, rash on left arm and on 27Mar2021 the patient was still experiencing fever, headache and overall malaise. No therapeutic measures were taken for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, chills, sweats, body aches, nausea, diarrhoea, rash on left arm, headache and overall malaise was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1463137
Sex: U
Age:
State: FL

Vax Date: 03/14/2021
Onset Date: 03/16/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fingernail showed black and blue spots; This is a spontaneous report from a contactable healthcare professional, the patient. A 61-year-old patient of unknown gender, received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN) in the left arm on 14Mar2021 at 12:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was reported as none and the patient was allergic to epinephrine. Prior to vaccination, the patient was diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 16Mar2021, 2 days after vaccination, the patient experienced fingernail discoloration, where 3 of the fingernails showed black and blue spots. No therapeutic measures were taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fingernail discoloration was not recovered at the time of this report. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1463138
Sex: F
Age:
State: MD

Vax Date: 03/17/2021
Onset Date: 03/17/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Severe pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208), via an unspecified route of administration in the left arm on 17Mar2021 at 02:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included lower back pain. The patient received other medications (unspecified) within two weeks of vaccination. The patient had no known allergy, only stomach upset with past drugs aspirin and ADVIL. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 19:00, the patient experienced severe pain at injection site does not go away so far (10 days after injection). The patient received TYLENOL 650mg as treatment for the event severe pain at injection site but it does not help her much. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of severe pain at injection site was not resolved at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1463139
Sex: F
Age:
State: CO

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: continuous runny nose; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via unspecified route of administration in the left arm on 23Mar2021 at 23:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had medical history of lupus, sjogrens syndrome, major depressive disorder and neurological tic disorder. Concomitant medications included hydroxychloroquine (MANUFACTURER UNKNOWN), ZOLOFT, hydroxyzine (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN). The patient reported allergies to chamomile and turmeric. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 12:00, the patient experienced continuous runny nose which was reported as a clear, liquid with constant stream. The patient did not receive any treatment measure for the reported events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of event continuous runny nose was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROXYCHLOROQUINE; ZOLOFT; GABAPENTIN; HYDROXYZINE

Current Illness:

ID: 1463140
Sex: F
Age:
State: IA

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Horrible body aches/all over body pain; extreme pain in both hips; severe migraine; nausea; diarrhea; no appetite; Fever; exhaustion; nightmares; skin sensitivity; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via an unspecified route of administration in the left arm on 25Mar2021 at 14:15 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history included migraine. Concomitant medication included levothyroxine (MANUFACTURER UNKNOWN), 112 mg, from unknown date for unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Lot Number: EN6199), via unspecified route of administration in the left arm on 04Mar2021 at 14:30 (at the age of 52-years-old), as a single dose for COVID-19 immunisation and clarithromycin (BIAXIN) on unknown date for unspecified indication and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 26Mar2021 at 04:00, the patient experienced horrible body aches, extreme pain in both hips, severe migraine, nausea, diarrhea, no appetite, fever, exhaustion, nightmares, skin sensitivity, literal all over body pain. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events body aches, pain in both hips, migraine, nausea, diarrhea, no appetite, fever, exhaustion, nightmares and skin sensitivity was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1463141
Sex: F
Age:
State: VA

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Ringing in both ears; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER 8732) via an unspecified route of administration in the left arm on 24Mar2021 at 10:45 (at the age of 60-year-old), as a single dose for COVID-19 immunisation. Medical history included Chronic Obstructive Pulmonary Disease (COPD). The patient was allergic to collins, sulpha base and blue berries. Concomitant medications included NAZARETH (unspecified medication) and albuterol inhaler (MANUFACTURER UNKNOWN) for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced ringing in both ears on 24Mar2021 at 20:30. The patient did not receive treatment for the reported events. The events neither resulted in doctor or other healthcare professional office/clinic visit nor emergency room/department or urgent care. The clinical outcome of ringing in both ears was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: Albuterol

Current Illness:

ID: 1463142
Sex: F
Age:
State: NJ

Vax Date: 03/11/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Rolling over in bed, with vertigo.; Im feeling nauseous; headache; headache and intermittent spinning; I also feel tired; This is a spontaneous report from a contactable nurse, the patient. A 64-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: En6206) via an unspecified route of administration in the left arm 11Mar2021(at the age of 64-years-old) at 12:00 as a single dose for COVID-19 immunisation. Medical history included Celiac do (as reported), hypothyroidism and hypertension. The patient was allergic to gluten, avelox and amoxicillin. The concomitant medications included vitamins (unspecified), thyroid medicine (unspecified) and amlodipine (MANUFACTURER UNKNOWN). Prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines in four weeks prior to COVID-19 vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021, two weeks after receiving the vaccine, the patient woke up at 02:00 after rolling over in bed, with vertigo. It had been 3 days and the patient was feeling nauseous, had headache with intermittent spinning that stopped only after closing the eyes. The patient also felt tired. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events vertigo, nausea, headache, head spinning and tiredness was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE

Current Illness:

ID: 1463143
Sex: F
Age:
State: PA

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chills; Body aches; Fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration in the left arm on 26Mar2021 at 10:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks of vaccination. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration in the left arm on 03Mar2021 at 11:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 26Mar2021, 12 hours after vaccination the patient experienced chills, body aches, fever and headache (felt like a sinus headache) that lasted all evening into the following day and all events subsided approximately 24 hours later. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and the emergency room/department or urgent care. The clinical outcome of the events chills, body aches, fever and headache were recovered on 27Mar2021 after the duration of 24 hrs. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1463144
Sex: F
Age:
State: CO

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itching scalp; sore to touch; A small lump developedon left side of scalp; This is a spontaneous report from a contactable patient. A 55-year-old-non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727) via unspecified route of administration in the left arm on 26Mar2021 at 15:45 PM (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included vitamin D (MANUFACTURER UNKNOWN) and magnesium (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. The patient did not have allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 23:45, the patient experienced itching scalp and small lump developed on left side of scalp which was sore to touch. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of events such as itching scalp and small lump developed on left side of scalp which was sore to touch was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: MAGNESIUM

Current Illness:

ID: 1463145
Sex: M
Age:
State: VA

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain in right arm; mild itching all over; neck pain opposite of injection site; joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7533) via unspecified route of administration in the right arm on 27Mar2021 at 17:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included overweight. Concomitant medications were not reported. It was unknown if the patient had any known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. On 28Mar2021 at 10:00, the patient experienced pain in right arm, mild itching all over, neck pain opposite of injection site and mild joint pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events pain in extremity, pruritus, neck pain and arthralgia were resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1463146
Sex: F
Age:
State: PA

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: dizzy/lightheaded/about to faint; head was spinning; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 27Mar2021 at 18:00 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included atorvastatin (MANUFACTURER UNKNOWN), vitamins (MANUFACTURER UNKNOWN), herbal (MANUFACTURER UNKNOWN); all for unknown indication. The patient did not have allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE Lot Number: EN6199), via unspecified route of administration in the left arm on 06Mar2021 at 18:15 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 27Mar2021 at 22:00, 4 hours after the vaccine, the patient had experienced extremely dizzy, lightheaded, where her head was spinning and about to faint. She immediately lay down on kitchen floor. It took many repeats of standing up and lying down for her to move to bedroom, where she stayed for the next few hours. Eventually, the patient was able to prepare for bed but moved slowly and would not fall although the dizzy, light headed feeling was not as intense. 16 hours later, she felt comfortable to move around and did not experience to dizzy feelings. The patient did not receive any treatment for the reported events. Adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dizzy/light headed/ about to faint and head was spinning was resolved on unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ATORVASTATIN

Current Illness:

ID: 1463147
Sex: F
Age:
State: CT

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: muscle soreness around the injection site.; Headache; Low grade fever; muscle pain; Joint soreness/ Pain; Tingling feeling in both legs; This is a spontaneous report from a contactable consumer, the parent. A 19-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration on 22Mar2021 (at the age of 19_years-old), as a single dose for COVID-19 immunisation. Medical history included environmental allergy (like pollen and dust). Concomitant medication included unspecified immune-tolerance (MANUFACTURER UNKNOWN) therapy for allergy. Prior to vaccination, it was unknown if patient was diagnosed with COVID-19. Since the vaccination, it was unknown if patient had tested for COVID-19. It was unknown if patient received any other vaccines within 4 weeks prior to the COVID vaccine. On 22Mar2021 (within 24 hours), the patient experienced very common side effects or sequelae like muscle soreness around the injection site, headache, low-grade fever, and more generalized muscle; joint soreness or pain and side effect which was most unusual and disturbing was the tingling feeling the patient had (and was still experiencing without any diminution) in both of her legs. It was also reported that, as per doctor the patient was not experiencing any muscle weakness or numbness, then it was not guillainbarre syndrome (GBS), and she should come back if it worsened, but did not prescribe any course of treatment. Therapeutics measure was taken as a result of events vaccination site pain, headache, low grade fever, muscle pain and joint pain which included the treatment with ADVIL (over the counter nonsteroidal anti-inflammatory drug). The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events vaccination site pain, headache, low grade fever, muscle pain, pain, joint pain and tingling were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1463148
Sex: F
Age:
State: TN

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches; Weakness; Painful to move; Light headed when standing; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730), via an unspecified route of administration in the left arm, on 27Mar2021 at 12:00 (at the age 25-years-old) as a single dose for COVID-19 immunisation. Medical history included allergies to shellfish and peanuts. Concomitant medication included ethinylestradiol;norgestimate (ESTARYLLA) from unknown date for birth control. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unspecified route of administration in the left arm, on 25Feb2021 at 16:00 (at the age 25-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 27Mar2021 at 22:45, the patient experienced body aches, weakness, painful to move and light headed when standing. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the events general body pain, weakness, painful to move and light headed when standing were recovering at the time of this report. No follow-up attempts are needed. No further information expected.

Other Meds: ESTARYLLA

Current Illness:

ID: 1463149
Sex: M
Age:
State: OH

Vax Date: 03/27/2021
Onset Date: 03/01/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Ep7533) via an unspecified route of administration in the left arm on 27Mar2021 (at the age of 60-years-old) at 14:45 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021, the patient had experienced sore arm. The clinical outcome of the event sore arm was unknown at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1463150
Sex: M
Age:
State: OH

Vax Date: 03/20/2021
Onset Date: 03/20/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Extreme vomiting; stomach pain; back pain; Loss of appetite; fatigue; chest pain; This is a spontaneous report received from a contactable consumer, the patient. A 63-Year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP7534) as a single dose via an unspecified route of administration in her right arm on 20Mar2021 at 16:45 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. The patients medical history included kidney stones. The patient had no allergies to medications, food or other products. The patient received hydrochlorothiazide (MANUFACTURER UNKNOWN) for unknown indication medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 20Mar2021 at 21:00, the patient experienced extreme vomiting later same day of vaccination, chest pain, stomach pain, back pain, loss of appetite and fatigue. The patient did not receive treatment for the reported events. The events resulted in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events vomiting, chest pain, stomach pain, back pain, loss of appetite and fatigue were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1463151
Sex: F
Age:
State: WA

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Chills; vomiting; body aches; wobbly legs and arms/weakness in legs and arms; headache; nausea; lightheaded; Swollen and red and hot at the injection site; Swollen and red and hot at the injection site; Swollen and red and hot at the injection site; fatigue; swollen lymph node in chest; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208), via unspecified route of administration in the left arm on 22Mar2021 at 15:30 (at the age 53-years-old), as a single dose for COVID-19 immunisation. Medical history included chronic pericarditis. The patient was allergic to penicillin. Concomitant medications included colchicine (MANUFACTURER UNKNOWN) 20 mg, bifidobacterium infantis; lactobacillus acidophilus (PROBIOTIC), fish oil (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN); all from unknown dates for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198); via unspecified route of administration in the left arm on 01Mar2021 at 15:30 (at the age 53-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 22Mar2021 at 20:00, the patient experienced fever, chills, vomiting, body aches, wobbly legs and arms, headache, nausea, light-headed, swollen and red and hot at the injection site, fatigue, weakness in legs and arms and swollen lymph node in chest. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatments for the events. The clinical outcome of the events fever, chills, vomiting, body aches, headache, nausea, lightheaded, vaccination site swelling and vaccination site erythema and vaccination site warmth, fatigue, weakness in legs and arms and swollen lymph node in chest was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: COLCHICINE; Probiotic; FISH OIL

Current Illness:

ID: 1463152
Sex: M
Age:
State: GA

Vax Date: 03/21/2021
Onset Date: 03/23/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I have been feeling dizzy since the second day after receiving the vaccine.; This is a spontaneous report received from a contactable consumer, the patient. A 60-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via an unspecified route of administration in the left arm on 21Mar2021 at 12:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history were reported as sleep apnea, acid reflux and high cholesterol. Concomitant medication was reported as none. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. On 23Mar2021 at 18:00, it was reported as the patient felt dizzy since the second day after the vaccine was received. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The treatment received for the adverse event was reported as no. The clinical outcome of the event dizzy was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1463153
Sex: F
Age:
State: CA

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: low on energy; pain in the lymph node in the left armpit; fatigue; general body pain; chills; vaccination site pain; This is a spontaneous report received from a contactable consumer, the patient. A 44-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730), via an unspecified route of administration in the left arm on 26Mar2021 at 10:30 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN), quetiapine fumarate (SEROQUEL), clonazepam (MANUFACTURER UNKNOWN), fexofenadine hydrochloride (ALLEGRA) and caffeine, paracetamol and ibuprofen (IBUPRO); all taken for unknown indications and from unknown dates. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199), via an unspecified route of administration in the left arm on 03Mar2021 at 08:00 (at the age of 44-years). On 26Mar2021, the patient experienced the event pain at the injection point in the left arm. On 27Mar2021 at 11:00, the patient experienced fatigue, body aches, and chills and on 28Mar, 2021 at 08:00, the patient experienced pain in the lymph node in her left armpit and the patient felt low on energy and bit achy. The persistent pain in the lymph node was the reason, the patient reported the event. Treatment was taken as a result of lymph node pain with ibuprofen 200mg. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events vaccination site pain, fatigue, general body pain, chills, lymph node pain and energy decreased was not recovered. No follow-up attempts possible. No further information expected.

Other Meds: SEROQUEL; CLONAZEPAM; ALLEGRA; Ibupro; LAMOTRIGINE

Current Illness:

ID: 1463154
Sex: F
Age:
State: NY

Vax Date: 03/27/2021
Onset Date: 03/28/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Headache; Chills; Fatigue; Cough; body ache; Fever; stomaache; muscle pain; wrist pain; ankle pain; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: Unknown) via an unspecified route of administration in the left arm on 27Mar2021 at 13:45 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA), salbutamol (ALBUTEROL) for unknown indication from unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 28Mar2021 at 01:30, the patient experienced headache, chills, fatigue, cough, body ache, fever, stomach ache, muscle pain, wrist and ankle pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, chills, fatigue, cough, body ache, fever, stomach ache, muscle pain, wrist and ankle pain were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: BREO ELLIPTA; Albuterol

Current Illness:

ID: 1463155
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: I have taken both of the Pfizer BioNtech COVID vaccines, and surprisingly it made me feel better; This is a spontaneous report based on the information received by Pfizer from BioNTech (Reference #24877) and a contactable consumer (patient). A non-pregnant female patient of an unspecified age has received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: Unknown) via an unspecified site of administration and unknown date at single dose for covid-19 immunization. Patient medical history included triple negative breast cancer, human papilloma virus infection (HPV) from 2004 and carcinoma in situ from 2004, chemotherapy and radiation therapy. Patient undergone chemo and radiation for breast cancer which she truly believe is a result of the HPV virus. Patients concomitant medications were not reported. The patient previously took first dose of BNT62B2 (PFIZER-BIONTECH covid-19 vaccine, formulation: solution for injection, lot number: unknown) via an unspecified route of administration at single dose for covid-19 immunization. Patient reported that she was a patient with triple negative breast cancer with a history of HPV that was so severe in 2004 that It turned into carcinoma in situ. Patient have undergone chemo and radiation for breast cancer which she truly believes was a result of the HPV virus. It now appears that the cancer has recurred. Please note that she never drank, smoked, taken a single drug and had no genetic disposition to breast cancer, nor has any one in her family had breast cancer. That is why patient was convinced that her Breast Cancer was HPV driven, patient was fortunate to be treated by the world's foremost oncologist, but she was convinced that unless the HPV virus was taken into consideration in the medicine for my treatment, it will not work. She feels input from BioNtech could provide a ground-breaking dynamic to her treatment. Patient have taken both of the Pfizer BioNtech COVID vaccines, and surprisingly it made her feel better, her overall wellness related to cancer. This can be wishful thinking, but she doesn't think so. Patient read an article that you feel a Cancer Vaccine will be available in two years. She feels your research in regard to viruses is pivotal to managing cancer. She was the author of the Book which hit Best Seller list in 2005, and I am now working on the next version of the book. She collaborated with the world's most notable innovators who have changed the world including the co-creator of internet, so patient know how important innovation is especially to me now. Most importantly I have 3 children who need me. She was in the care of the best doctors in the world, but she truly believes that the HPV virus is a consideration in her health and treatment that must be controlled and is presently overlooked. This is the turning point for her, and she need help immediately. The outcome of event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1463156
Sex: F
Age:
State: IN

Vax Date: 03/25/2021
Onset Date: 03/27/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: vaginal bleeding; abdominal pain; This is a spontaneous report from a contactable consumer. A 21-years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: 8733) via an unspecified route of administration in the left arm on 25Mar2021 at 09:00 (at an age of 21 years) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had seasonal allergies. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: 6205) via unspecified route of administration in the left arm on 04Mar2021 at 09:00 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medications within two weeks of vaccination include medication for birth control. Prior to vaccination, the patient was not diagnosed for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 27Mar2021 at 09:00, after two days of the second dose of vaccine, the patient experienced spotting with light vaginal bleeding. The patient reported that she had been on birth control for almost three years and had never spotted, and the patient always had period on the same exact day (which was not supposed to happen for another 10 days). The patient also experienced abdominal pain while it was happening. The patient did not receive any treatment for adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events light vaginal bleeding and abdominal pain were unknown. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1463157
Sex: F
Age:
State: NC

Vax Date: 03/23/2021
Onset Date: 03/01/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: headaches and eye aches; headaches and eye aches; Blurry vision; Shortness of breath; aching in arms; pain at injection site; lost memory; States that it was like when she had the corona virus and she had brain fog, It felt like the end of the world; arms were very achy and heavy; Feels tired; States she has had Covid before and that this feels like Covid again; Feels like she got the flu.; Achy body; This is a spontaneous report from a contactable consumer reporting for herself. A 69-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6204), via an unspecified route of administration, administered in left arm on 23Mar2021 11:00 (at the age of 69-years-old) as a single dose for COVID-19 immunization (reported as had corona virus before and works with elderly people) at pharmacy. Medical history included urinary tract infection (UTI) from an unknown date to unknown date (reported as after she got the shot, she didn't have that problem with the UTI anymore), COVID on an unknown date in 2020, breathing from an unknown date and unknown if ongoing. Concomitant medications included albuterol (salbutamol) taken for breathing from 2020 and ongoing (has been taking since last year due to issues with breathing after having corona virus. Takes anytime she had short of breath. After shot, kept this for comfort); sulfamethoxazole, trimethoprim (BACTRIM) taken for UTI from Mar2021 and ongoing. On 23Mar2021, the patient experienced headaches and eye aches, blurry vision, shortness of breath, aching in arms, pain at injection site, feels like she got the flu, lost memory, states that it was like when she had the corona virus and she had brain fog, feels tired, it felt like the end of the world, arms were very achy and heavy, and states she has had COVID before and that this feels like COVID again. On an unspecified date in Mar2020, the patient experienced achy body. It was reported that "she has been having soreness in her arms, achy body and headaches. Caller stated she lost her memory after the first shot and couldn't find her way. When she got home, her arms were very achy and heavy and had shortness of breath. Her head was hurting, as well as her eyes and has blurred vision. Also has aching and soreness in her arms. She has had Covid before and that this feels like Covid again. Stated she had an awful Covid case and knows what she had then. Stated that these were some of the same things and wants to file a report about these symptoms. Lost memory: Stated that after she got in the car, she could not remember. Lost her realization of where she was going and got lost. States that it was like when she had the corona virus and she had brain fog. It felt like the end of the world. States that it lasted 30 minutes and that she had to turn around and wait. Was trying to think what in the world, then got some clarity. Headaches and eye aches: State the headaches were making it hard to concentrate. Headaches started the same day as the vaccine, about an hour after. Felt like her eyeballs were going to pop out of her head. Stated that when she had corona and had headaches, she felt like her brain was popping out of her head. States she was leery to get the shot. States her head started hurting again but no swelling on the inside, like when she had corona. Treatment included tried to take TYLENOL every couple of hours for headaches and eye aches, but they eventually started coming back and she still having headaches. Blurry vision: Started same day as the vaccine. States her eyesight still foggy and still had blurry vision. Treatment: Just Tylenol. Shortness of breath: Has been having shortness of breath since the day of the vaccine and has had a funny feeling. Felt like she couldn't breathe. Treatment: Took Albuterol which helped her calm down. States she was put on this during her Covid case. Aching in arms: Started the same day, later that afternoon. States she was sitting around waiting because she knew something was going to happen. States that her arms started feeling heavy and still feels that her arms are aching, right down her arm. Also states she still has pain at the injection site and feels tired. Feels like she got the flu. States she knows what she had with the corona virus. With the shot, she feels off. She didn't think she would make it. States she did not want to get it. Adverse events did not lead to emergency Room but may have to go. No Physician Office visit. No prior vaccinations within 4 weeks and no adverse events following prior vaccinations. Therapeutic measures were taken as a result of headaches and eye aches, blurry vision, shortness of breath, aching in arms, pain at injection site, and achy body. The outcome of events headaches, eye aches, blurry vision, aching in arms, pain at injection site was not recovered, lost memory was resolved on 23Mar2021, and all other events outcome was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds: ALBUTEROL [SALBUTAMOL]; BACTRIM

Current Illness:

ID: 1463158
Sex: M
Age:
State: CT

Vax Date: 03/23/2021
Onset Date: 03/24/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Lethargy; Body aches; Fever; Dry cough; Congestion in chest; loss of smell last night; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old adult male patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8732), via an unspecified route of administration in the left arm on 23Mar2021 at 13:30 (at the age of 54-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, high cholesterol, DM type 2. Concomitant medications included, fish oil (MANUFACTURER UNKNOWN), metformin hydrochloride (METFORMIN XR), atorvastatin (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN); used for unknown indication, from an unspecified date. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not tested for COVID-19 since the vaccination. On 24Mar2021 at 18:00, the patient experienced lethargy, body aches, fever, dry cough, congestion in chest and loss of smell last night. The patient did not receive treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events lethargy, body aches, fever, dry cough, congestion in chest and loss of smell was not recovered at the time this report. No follow-up attempts possible. No further information expected.

Other Meds: LISINOPRIL; FISH OIL; ATORVASTATIN; METFORMIN XR

Current Illness:

ID: 1463159
Sex: F
Age:
State: MN

Vax Date: 03/12/2021
Onset Date: 03/12/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fatigue; Headache; Joint pain; Knees inflamed and very red and hot to the touch; Both knees swollen; This is a spontaneous report from a contactable consumer, the patient. A 70 years-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208) via an unspecified route of administration in the arm left on 12Mar2021at 10:45 (at the age of 70-years-old) as a single dose for COVID-19 Immunisation. Medical history was reported as high blood pressure, high cholesterol and hypothyroidism. Concomitant medications were reported as Fosamax (MANUFACTURER UNKNOWN), Norvasc (MANUFACTURER UNKNOWN), Trazodone (MANUFACTURER UNKNOWN), Efferox (MANUFACTURER UNKNOWN) and Synthroid (MANUFACTURER UNKNOWN) for an unknown indication from unspecified date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6201) via an unspecified route of administration in the arm left on 19Feb2021 at 09:45 (at the age of 70-years-old) as a single dose for COVID-19 Immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not tested for COVID-19. The patient had allergies of penicillin and flu vaccine. On 12Mar2021 at 16:00, the patient experienced fatigue, headache, joint pain, both knees inflamed (joint inflammation) which was very red and hot to the touch with swollen (knee swelling). The patient did not receive treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fatigue, headache, joint pain, joint inflammation and knee swelling were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FOSAMAX; NORVASC; TRAZODONE; EFFEXOR; SYNTHROID

Current Illness:

ID: 1463160
Sex: F
Age:
State: CA

Vax Date: 03/18/2021
Onset Date: 03/24/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Supraclavicular lymph node swelling in arm of injection (right); This is a spontaneous report from a contactable consumer, the patient. A 27-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the right arm on 18Mar2021 at 14:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included Ehlers Dalnos Syndrome type 3, postural orthostatic tachycardia syndrome, mast cell activation syndrome, hashimotos hypothyroidism, epilepsy, autoimmune chronic urticaria and angioedema on an unspecified date. The patient was on concomitant medications, names unspecified. The patient had known allergies to penicillin, cefazolin (MANAFACTURER UNKNOWN), hydrocodone; acitomenophen (VICODIN), and topiramate (MANAFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced supraclavicular lymph nodes enlarged on 24Mar2021. (Supraclavicular lymph node swelling in arm of injection (right) 6 days after vaccine). Treatment was not received for the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Clinical outcome of supraclavicular lymph nodes enlarged was not recovered. No follow up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1463161
Sex: F
Age:
State: TN

Vax Date: 03/26/2021
Onset Date: 03/27/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Nauseous; lethargic; tired; sore arm; feel out of it; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 26Mar2021 at 14:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient was allergic to sulfur. Concomitant medication included magnesium (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN), ester C (MANUFACTURER UNKNOWN) and hydrochlorothiazide (MANUFACTURER UNKNOWN) for unspecified indications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27Mar2021 at 09:00, the patient experienced tiredness, lethargic, nauseous, sore arm/pain in arm, feel out of it/confusion state. The adverse events did not result in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for the reported events. The clinical outcome of tiredness, lethargic, nauseous, sore arm and feel out of it/confusion state was not recovered at this time of report. Information about lot number cannot be obtained. No further information is expected.

Other Meds: MAGNESIUM; ZINC; Ester C

Current Illness:

ID: 1463162
Sex: F
Age:
State: CA

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Metal taste within minutes of the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old not pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA vaccine; Lot number: Unknown), via an unspecified route of administration in left arm on 26Mar2021 at 14:30 (at age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic sinusitis. The patient did not have any known allergies to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient was not diagnosed with Covid-19 prior to vaccination. The patient had not been tested for Covid-19 since the vaccination. On 26Mar2021 at 14:30, the patient had metal taste within minutes of the vaccine. The patient did not receive any therapeutic measure for the reported event. Adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event metal taste within minutes of the vaccine was resolving at the time of report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1463163
Sex: F
Age:
State: CA

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Increasingly worse stomach cramping; loose bowel movements; This is a spontaneous report from a contactable other health care professional. A 59-year-old female non pregnant patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: Unknown), via an unspecified route of administration on the right arm on 24Mar2021 at 12:00 (at the age of 59-year-old), as a first single dose for COVID-19 immunisation. Medical history included hashimotos thyroiditis. Concomitant medications included: Estradiol (VAGIFEM), Thyroid (ARMOUR THYROID) 120 mg, turmeric (MANUFACTURER UNKNOWN) and ginger (MANUFACTURER UNKNOWN) all for an unknown indication. The patient was allergic to celiacs sprue and latex. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021, at 18:00 the patient experienced increasingly worse stomach cramping with loose bowel movements. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events increasingly worse stomach cramping and loose bowel movements was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ARMOUR THYROID; VAGIFEM

Current Illness:

ID: 1463164
Sex: F
Age:
State: CA

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: mild arm discomfort; general odd feeling for two days.; Slight headache; nausea; eyes and other parts of body got pink and started itching; other parts of body got pink and started itching; vision blurred and darkened, felt like store was closing in.; When stood up to move away from people for further observation, felt dizziness; Eyes and other parts of body got pink and started itching; eyes and other parts of body got pink and started itching; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730), via an unspecified route of administration in the left arm on 24Mar2021 at 13:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient was allergic to latex, eucalyptus, ginger, cardamom, nutmeg, cilantro, coriander and cloves. The patient received unspecified concomitant medications. The patient previously erythromycin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 13:10, the patient experienced vision blurred and darkened, felt like store was closing in. When the patient stood up to move away from people for further observation, the patient felt dizziness and nausea. Her eyes and other parts of her body got pink and started itching. The patient stayed on site for 45 minutes. The vision returned to normal and dizziness passed. Nausea, pink and itchy skin (in a few places) remained. Over the next two days on 26Mar2021, the patient experienced itchiness and pinkness moved around her body. The patient also experienced slight headache, mild arm discomfort and general odd feeling for two days. The patient did not receive any treatment for the events vision blurred, dizziness on standing up, pinkeye, itchy eyes, arm discomfort, feeling bad, nausea, itchy skin, headache and skin discolouration. The clinical outcomes of the events vision blurred, dizziness on standing up, pinkeye, itchy eyes, arm discomfort, feeling bad, nausea, itchy skin, headache and skin discolouration were recovering at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1463165
Sex: F
Age:
State: NC

Vax Date: 03/22/2021
Onset Date: 03/22/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: increased heart rate within an hour of injection; Headache; injection site soreness; This is a spontaneous report from a contactable nurse, the patient. A 49-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: ER8727), via an unspecified route of administration on 22Mar2021 at 09:30 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included restless leg syndrome. The patient did not have any allergies to food, medications, or other products. Concomitant medications included pramipexole dihydrochloride monohydrate (MIRAPEX), tramadol hydrochloride (ULTRAM), magnesium (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN), all for unknown indications from unknown dates. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had not received any other vaccines within four weeks prior to the COVID vaccine. On 22Mar2021 at 09:45, the patient experienced headache for five days and injection site soreness for two days. At 10:30 (reported as within an hour of injection), the patient experienced increased heart rate. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events headache, vaccination site pain and heart rate increased. The clinical outcome of the event vaccination site pain was recovered on 24Mar2021; headache was recovered on 27Mar2021 and that of heart rate increased was recovered on an unknown date in Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: MIRAPEX; Ultram; MAGNESIUM; IBUPROFEN

Current Illness:

ID: 1463166
Sex: F
Age:
State: IL

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swollen lymph node (left axillary); severe fatigue; muscle weakness; This is a spontaneous report from a contactable other health care professional, the patient. A 25-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264), via an unspecified route of administration in the left arm on 12Feb2021 (at the age of 25-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number:EN6206), via an unspecified route of administration in the left arm on 26Mar2021(at the age of 25-years-old); as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received amoxicillin (MANUFACTURER UNKNOWN) and metoclopramide (REGLAN); both on unknown dates for unspecified indications and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had tested for COVID-19. On an unspecified date in 2021, the patient experienced swollen lymph node (left axillary), severe fatigue and muscle weakness. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient underwent lab test and procedures which included COVID test (nasal swab) on 26Mar2021 and tested negative. The clinical outcome of the events swollen lymph node, severe fatigue and muscle weakness were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1463167
Sex: F
Age:
State: AR

Vax Date: 03/26/2021
Onset Date: 03/26/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizzy and lightheaded; Over 24 hours after vaccine, still sore in joints and muscles; Over 24 hours after vaccine, still sore in joints and muscles; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 26Mar2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included gluten allergy. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 16:00, the patient felt sore in joints and muscles, dizzy and lightheaded. Over 24 hours after vaccine, the patient had still sore in joints and muscles, dizzy and lightheaded. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events dizzy, muscle soreness and soreness of joint. The clinical outcomes of the events dizzy, muscle soreness and soreness of joint were not recovered at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1463168
Sex: F
Age:
State: MO

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: loss of smell; Loss of taste; High fever; chills; sweats; Aches; fatigue; Swollen hard arm; Broke out with fever blisters nose mouth and lips; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via the unspecified route of administration in the right arm on 24Mar2021 at 13:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks of the COVID vaccination. The patient did not receive any medications within two weeks of the COVID-19 vaccination. On 25Mar2021 at 03:00, the patient experienced high fever, chills, sweats, aches, fatigue, swollen hard red arm for five-plus days, fever blisters in nose mouth and lips. On 28Mar2021 (day 5), the patient experienced the loss of smell and taste. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the adverse events. The clinical outcome of the events high fever, chills, sweats, aches, fatigue was resolved in 48 hours on 27Mar2021; while the events of the swollen hard red arm, fever blisters, loss of smell and loss of taste was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1463169
Sex: F
Age:
State:

Vax Date: 03/28/2021
Onset Date: 03/28/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Stiff arm; slightly sore/stiff arm; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 28March2021 at 10:15 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to food, medications, or other products. Concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Mar2021, the patient had only a slightly sore/stiff arm and the patient could still do her workouts without any problems. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The ice helped the patient with the pain and stiffness. The clinical outcomes of the events stiffness and pain in arm were recovering at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1463170
Sex: F
Age:
State: CA

Vax Date: 03/13/2021
Onset Date: 03/14/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Two weeks early menstrual bleeding; Two weeks early menstrual bleeding, including clotting and mucus; two weeks early menstrual bleeding, including clotting and mucus accompanied by cramps; Fatigue; headache; body pain; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old-non-pregnant female patient received her first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6208) via unspecified route of administration in the left arm on 13Mar2021 at 15:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient medical history included autoimmune disease. The patient was allergic to morphine, gluten and dairy. Concomitant medication included thyroid (ARMOUR THYROID) medication. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Mar2021, the patient underwent nasal swab test and tested negative for COVID-19. The patient was not diagnosed with COVID-19 prior to vaccination. On 14Mar2021, the patient experienced two weeks early menstrual bleeding, including clotting and mucus accompanied by cramps, fatigue, headache, and body pain lasted for more than 7 days. The patient did not receive treatment for the reported events. The events resulted in the doctor or other healthcare professional office/clinic visit. The clinical outcome of all events was unknown at this time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: ARMOUR THYROID

Current Illness:

ID: 1463171
Sex: F
Age:
State: CT

Vax Date: 03/24/2021
Onset Date: 03/25/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: felt hot and cold through day; muscle aches; mild headache; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 24Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the right arm on 01Mar2021 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 25Mar2021, the patient had experienced hot and cold feeling throughout the day, muscle aches, mild headache and fatigue. The clinical outcomes of the events feeling hot and cold, muscle aches, mild headache, and fatigue were recovered on an unknown date in Mar2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1463172
Sex: F
Age:
State: PA

Vax Date: 03/04/2021
Onset Date: 03/01/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling under left armpit into left breast area; shoulder blade area feels like a stiff neck sore to turn head to the left; shoulder and shoulder blade very sore on left side wrist up to neck back; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6199), via an unspecified route of administration in the left arm on 04Mar2021 at 19:30 (at the age of 52-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534), via an unspecified route of administration in the left arm on 25Mar2021 at 19:30 (at the age of 52-years-old), as single doses for COVID-19 immunisation. The patient had no medical history reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On an unknown date in Mar2021 at 05:00, the patient had swelling under left armpit into left breast area, shoulder and shoulder blade was very sore on left side wrist up to neck back and shoulder blade area felt like a stiff neck, sore to turn head to the left. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events swelling under left armpit into left breast area, shoulder and shoulder blade very sore on left side wrist up to neck back and shoulder blade area feels like a stiff neck sore to turn head to the left. The clinical outcomes of the events swelling under left armpit into left breast area, shoulder and shoulder blade very sore on left side wrist up to neck back and shoulder blade area feels like a stiff neck sore to turn head to the left were not recovered at the time of the report. No follow-up attempts are needed. No further information is expected

Other Meds:

Current Illness:

ID: 1463173
Sex: F
Age:
State: WA

Vax Date: 03/25/2021
Onset Date: 03/27/2021
Rec V Date: 07/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Achy; Nausea; Slight fever (barely 99); Chills; Exhaustion; swollen lymph nodes of neck; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: ER 8730) via an unspecified route of administration in the left arm on 25March2021 at 13:45 as a single dose for COVID-19 immunisation. Patient medical history was kidney stones, long COVID-19 infection. Concomitant medications included clonazepam (MANUFACTURER UNKNOWN), mirtazapine (MANUFACTURER UNKNOWN), vitamins and aluminium hydroxide, magnesium trisilicate, sodium alginate (PEPCID) received within 2 weeks of vaccination. The patient was allergic to dairy and sulfa based antibiotics. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, it was unknown whether patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 27March2021, the patient experienced nausea, slight fever of 99 degree Celsius, chills, exhaustion, swollen lymph nodes in neck, ache. No therapeutic measures were taken for the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events nausea, fever, chills, exhaustion, swollen lymph nodes in neck, ache were unknown at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds: CLONAZEPAM; MIRTAZAPINE; Pepcid

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm